Quantcast

Latest Clinical research Stories

2014-06-16 12:29:16

Aspire IRB and Midlands IRB become part of the WCG family, further expanding its geographic and program reach PRINCETON, N.J., June 16, 2014 /PRNewswire/ -- The WIRB-Copernicus Group ("WCG"), the world's largest provider of regulatory and ethical review services for clinical research, announced today that two independent review boards (IRBs) - Aspire IRB and Midlands IRB - have joined the Group. Located near San Diego, CA and Kansas City, MO, respectively, these companies expand...

2014-06-16 12:28:52

ATLANTA, June 16, 2014 /PRNewswire/ -- Avion Pharmaceuticals, LLC, a specialty pharmaceutical company, announces positive feedback on two New Drug Applications (NDA) with projected approvals of late 2016 and early 2017. Based on the feedback from the Food and Drug Administration (FDA) Avion will be moving into Phase II/III on one NDA Program, and into Phase II on the other. In line with Avion's strategic corporate mission, both NDAs are in the women's health category. "We are very...

2014-06-16 12:28:49

Underscoring its Commitment to Patient Advocacy and Care, My Clinical Study Buddy(SM) Mobile Apps to Help Boost Patient Engagement SAN DIEGO and BOSTON, June 16, 2014 /PRNewswire/ -- DIA 2014 50(th) Annual Meeting -- BBK Worldwide, a leading clinical trial marketing firm, today unveiled two new mobile apps for patient and site engagement, My Clinical Study Buddy(SM) and My Clinical Study Buddy(SM) Protocol Pointers Edition. Available for Apple(®) and Android((TM)) mobile phones and tablets,...

2014-06-16 12:28:45

New R&D Model Protects Performance in a Threatened Enrollment Landscape SAN DIEGO and BOSTON, June 16, 2014 /PRNewswire/ -- DIA 2014 50(th) Annual Meeting -- BBK Worldwide, the leader in patient recruitment, today unveiled a new specialty in clinical trial marketing: adaptive recruitment. Designed specifically to protect global enrollment integrity, within a changing or threatened landscape, adaptive recruitment helps sites and sponsors maximize tight budgets and timeframes by...

2014-06-16 12:25:48

Mobile app and electronic clinical outcome assessment technology provide easy to use solutions for clinical trials SAN DIEGO, June 16, 2014 /PRNewswire/ -- Bracket, a leading clinical trial specialty service provider, is demonstrating their most recent eClinical innovations this week at the 50th Annual Meeting of the Drug Industry Association. A mobile app, part of Bracket's Randomization and Trial Supply Management System (RTSM ) and Clinical Interactive Response Technologies...

2014-06-16 08:29:54

? eClinical Leader adds Risk-Based Monitoring Technology to Platform ? NEWTOWN, Pa., June 16, 2014 /PRNewswire/ -- BioClinica®, Inc., a leading provider of eClinical Solutions for the Pharmaceutical Industry, has announced the acquisition of Blueprint Clinical, a fast-growing company offering ground-breaking technology and extensive expertise to drive successful Risk-Based Monitoring (RBM) strategies for clinical trials. This move adds Compass, a cloud-based site scoring tool to the robust...

2014-06-16 08:29:45

PHILADELPHIA, June 16, 2014 /PRNewswire/ -- TransCelerate BioPharma Inc. ("TransCelerate") is launching two new global initiatives enabled by broad participation and collaboration across the global research and development (R&D) community: develop a position on the best and most efficient methods for redacting privacy information found in clinical study reports and an approach for the anonymization of patient level data shared with the broader healthcare community; and develop a...

2014-06-16 08:28:27

SAN DIEGO, June 16, 2014 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative genetic analysis solutions, announced today that it has received premarket 510(k) clearance from the United States Food and Drug Administration (FDA) to market its IMPACT Dx(TM) Factor V Leiden and Factor II Genotyping Test and the IMPACT Dx(TM) System. The IMPACT Dx Factor V Leiden and Factor II Genotyping Test is performed on the IMPACT Dx System, and is indicated...

2014-06-15 08:20:51

LONDON, June 15, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Hormone Refractory Breast Cancer Global Clinical Trials Review, H1, 2014http://www.reportbuyer.com/pharma_healthcare/drug_discovery/hormone_refractory_breast_cancer_global_clinical_trials_review_h1_2014.htmlHormone Refractory Breast Cancer Global Clinical Trials Review, H1, 2014 SummaryGlobalData's clinical trial report, "Hormone Refractory Breast Cancer Global Clinical Trials...

2014-06-14 23:01:16

The hot topics on Monday, June 16 SAN DIEGO (PRWEB) June 14, 2014 Game-changing patient engagement in the drug development process, the current U.S. drug regulatory landscape and bioinnovation are among the hot topics on Monday, June 16, at the DIA 2014 50th Annual Meeting at the San Diego Convention Center. A new DIA event, The Walking Gallery, will bring life to patient stories through art. Patient Voice in Drug Development At the opening plenary session, patient engagement and...


Word of the Day
baudekin
  • A rich embroidered or brocaded silk fabric woven originally with a warp of gold thread.
'Baudekin' seems to be an alternative form of 'baldachin,' from the Italian 'Baldacco,' Baghdad, the city where the material was made.
Related